Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TKNO | US
0.12
4.49%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
13/03/2026
2.79
2.67
2.90
2.67
Alpha Teknova Inc. produces critical reagents for the research discovery development and commercialization of novel therapies vaccines and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation resuspension and purification. It serves life sciences market including pharmaceutical and biotechnology companies contract development and manufacturing organizations in vitro diagnostic franchises and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister California.
View LessLow Market Beta (-0.4 to 0.8)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
137.7%1 month
104.1%3 months
82.6%6 months
79.2%-
-
4.23
0.39
0.27
-6.23
9.90
-
-23.44M
148.72M
148.72M
-
-53.05
-
-16.60
-41.51
2.05
1.32
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.93
Range1M
0.99
Range3M
3.03
Rel. volume
0.91
Price X volume
468.72K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 0.8817 | 133.73M | -4.98% | n/a | -471.04% |
| Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 1.02 | 113.05M | -1.92% | n/a | 117.00% |
| CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.02 | 81.21M | -2.86% | n/a | 1.07% |
| Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 2.542 | 60.11M | 4.61% | n/a | 24.34% |
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 3.04 | 42.85M | -1.62% | n/a | 81.86% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 7.34 | 39.25M | -8.82% | n/a | 0.00% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.79 | 36.15M | 0.00% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 0.8588 | 32.51M | -3.54% | n/a | 25.73% |
| Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0575 | 24.14M | 4.17% | n/a | 0.00% |
| India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.283 | 21.41M | -0.04% | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 8.44 | 135.52M | -11.16% | n/a | 286.96% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.36 | 103.60M | 0.79% | 9.09 | 39.79% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 35.24 | 101.20M | -1.07% | 5.16 | 19.82% |
| Unifi Inc | UFI | Textile Manufacturing | 3.63 | 66.27M | -0.55% | n/a | 52.56% |
| ILAG | ILAG | Building Products & Equipment | 2.2 | 39.73M | -2.22% | n/a | 5.48% |
| Culp Inc | CULP | Textile Manufacturing | 2.96 | 36.97M | 4.59% | n/a | 11.29% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.86 | 27.18M | -9.27% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5697 | 11.01M | 0.96% | n/a | 58.43% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.4302 | 6.62M | n/a | 422.08% | |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.3803 | 3.62M | -3.79% | n/a | 19.98% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.23 | - | Cheaper |
| Ent. to Revenue | 9.90 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 4.23 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 82.63 | - | Riskier |
| Debt to Equity | 0.39 | -1.88 | Expensive |
| Debt to Assets | 0.27 | 0.48 | Cheaper |
| Market Cap | 148.72M | - | Emerging |